Natural Alternatives International Inc. (NAI) has released its financial results for the fiscal year ending June 30, 2025. The company reported a notable increase in private-label contract manufacturing sales, which rose by 16% to $121.8 million, compared to $105.4 million in the previous fiscal year. This growth highlights the company's focus on expanding its services in providing private-label manufacturing for vitamins, minerals, herbal, and other nutritional supplements, as well as other healthcare products. NAI's revenue has historically been dependent on sales to two or three major private-label customers. The company continues to improve operational efficiencies and manage costs and business risks to enhance profitability. The report also includes a discussion of critical accounting estimates, particularly in revenue recognition, highlighting the importance of precise estimations in contracts with volume rebates. The company did not provide specific forward-looking guidance or detailed outlook in the report.